Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia R Smith

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Huntington'S Disease|February 25, 2022
Temporal Phenotypic Changes in Huntington's Disease Models for Preclinical StudiesSophie St-Cyr, Alicia R Smith, Beverly L Davidson
Plos One|August 29, 2022
Huntington's disease phenotypes are improved via mTORC1 modulation by small molecule therapySophie St-Cyr, Daniel D Child, Emilie Giaime, et al.
Neurotoxicology|July 8, 2024
Identification of neural-relevant toxcast high-throughput assay intended gene targets: Applicability to neurotoxicity and neurotoxicant putative molecular initiating eventsCina M Mack, Alethea Tsui-Bowen, Alicia R Smith, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
Nature Communications|June 25, 2025
AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 miceDefne A Amado, Ashley B Robbins, Katherine R Whiteman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Huntington'S Disease|February 25, 2022
Temporal Phenotypic Changes in Huntington's Disease Models for Preclinical StudiesSophie St-Cyr, Alicia R Smith, Beverly L Davidson
Plos One|August 29, 2022
Huntington's disease phenotypes are improved via mTORC1 modulation by small molecule therapySophie St-Cyr, Daniel D Child, Emilie Giaime, et al.
Neurotoxicology|July 8, 2024
Identification of neural-relevant toxcast high-throughput assay intended gene targets: Applicability to neurotoxicity and neurotoxicant putative molecular initiating eventsCina M Mack, Alethea Tsui-Bowen, Alicia R Smith, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
AAV-based delivery of RNAi targeting Ataxin-2 improves survival, strength, and pathology in mouse models of rapidly and slowly progressive sporadic ALSDefne A Amado, Ashley B Robbins, Alicia R Smith, et al.
Nature Communications|June 25, 2025
AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 miceDefne A Amado, Ashley B Robbins, Katherine R Whiteman, et al.
Pageof 1